Search results
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 30 minutes agoThe simplest way to benefit from a rising market is to buy an index fund. But if you buy individual...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 1 hour agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
Zacks via Yahoo Finance· 14 hours agoThe latest trading session saw Bristol Myers Squibb (BMY) ending at $41.77, denoting a +1.65%...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 19 hours agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
California State Teachers Retirement System Purchases 60,431 Shares of Bristol-Myers Squibb...
ETF DAILY NEWS· 1 day agoCalifornia State Teachers Retirement System grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the fourth quarter, according to its most recent 13F filing with ...
Fork Cancer fundraiser to bring delicious food, live music to Lunken Airport
The Enquirer via Yahoo News· 12 hours agoPartying for a good cause? Fork yeah! Fork Cancer, an inaugural event presented by global biopharmaceutical company Bristol Myers Squibb, is seeking to raise awareness and support for the American ...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 4 days agoBristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration for...
Bristol-Myers Squibb Co. [BMY] Investment Appeal on the Rise – Knox Daily
Knox Daily· 6 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biopharmaceutical company have returned -9%, compared to the Zacks S&P 500 ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 20 hours agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company paid nearly $5 billion ...